middle.news

Island advances Galidesivir toward pivotal Marburg testing

10:32am on Tuesday 17th of November, 2026 AEDT • Biotechnology and Pharmaceuticals
Read Story

Island advances Galidesivir toward pivotal Marburg testing

10:32am on Tuesday 17th of November, 2026 AEDT
Key Points
  • Marburg dose-response study expected to begin in early December 2026
  • Company reported 94% survival in a treated Marburg primate model versus 0% for placebo
  • FDA confirmed the Animal Rule pathway and advised Galidesivir may qualify for a Tropical Disease Priority Review Voucher
  • Uganda MEURI program could generate prospective human safety and virological data in 2027
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE